Canada Pension Plan Investment Board
LRMR icon

Canada Pension Plan Investment Board’s Larimar Therapeutics LRMR Stock Holding History

Canada Pension Plan Investment Board’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$269K Sell
59,700
-34,300
-36% -$137K ﹤0.01% 1466
2025
Q4 		$358K Buy
+94,000
New +$366K ﹤0.01% 1440
2019
Q2 		– Sell
-187
Closed -$6K – 1376
2019
Q1 		$6K Buy
+187
New +$9.59K ﹤0.01% 1445

Other funds holding LRMR

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Canada Pension Plan Investment Board's LRMR Position: Q1 2026 in Review

Canada Pension Plan Investment Board reduced its Larimar Therapeutics (LRMR) stake by 36% in Q1 2026, selling an estimated $137K and leaving 59,700 shares worth $269K. The position accounts for ﹤0.01% of the portfolio, ranked #1466.

Canada Pension Plan Investment Board first reported a position in LRMR in Q1 2019 and has held it in 3 quarters since. The position peaked at $358K in Q4 2025. 162 funds tracked by Wall St. Rank hold LRMR as of Q1 2026.

  • Canada Pension Plan Investment Board held 59,700 shares of Larimar Therapeutics worth $269K as of Q1 2026.
  • Canada Pension Plan Investment Board sold 34,300 Larimar Therapeutics shares in Q1 2026, an estimated $137K.
  • Larimar Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #1466 holding.
  • Canada Pension Plan Investment Board first reported a position in Larimar Therapeutics in Q1 2019 and has held it in 3 quarters since.
  • Canada Pension Plan Investment Board's Larimar Therapeutics position peaked at $358K in Q4 2025.
  • 162 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.